1.Clinical characteristics and CT findings of Pneumocystis Jirovecii pneumonia in 46 cases with hematological diseases.
Hui Ming YI ; Chun Hui XU ; Dong Lin YANG ; Qing Song LIN ; Ying LI ; Hong Yan SUN ; Si Zhou FENG
Chinese Journal of Hematology 2023;44(2):118-123
		                        		
		                        			
		                        			Objective: To summarize the original CT features of Pneumocystis Jirovecii pneumonia in patients with hematological diseases. Methods: A retrospective analysis was carried out in 46 patients with proven pneumocystis pneumonia (PJP) in the Hospital of Hematology, Chinese Academy of Medical Sciences between January 2014 and December 2021. All patients had multiple chests CT and related laboratory examinations, imaging typing were conducted based on the initial CT presentation, and the distinct imaging types were analyzed against the clinical data. Results: In the analysis, there were 46 patients with proven pathogenesis, 33 males, and 13 females, with a median age of 37.5 (2-65) years. The diagnosis was validated by bronchoalveolar lavage fluid (BALF) hexamine silver staining in 11 patients and clinically diagnosed in 35 cases. Of the 35 clinically diagnosed patients, 16 were diagnosed by alveolar lavage fluid macrogenomic sequencing (BALF-mNGS) and 19 by peripheral blood macrogenomic sequencing (PB-mNGS) . The initial chest CT presentation was categorized into 4 types, including ground glass (GGO) type in 25 cases (56.5%) , nodular type in 10 cases (21.7%) , fibrosis type in 4 cases (8.7%) , and mixed type in 5 cases (13.0%) . There was no substantial discrepancy in CT types among confirmed patients, BALF-mNGS diagnosed patients and PB-mNGS diagnosed patients (χ(2)=11.039, P=0.087) . The CT manifestations of confirmed patients and PB-mNGS diagnosed patients were primarily GGO type (67.6%, 73.7%) , while that of BALF-mNGS diagnosed patients were nodular type (37.5%) . Of the 46 patients, 63.0% (29/46) had lymphocytopenia in the peripheral blood, 25.6% (10/39) with positive serum G test, and 77.1% (27/35) with elevated serum lactate dehydrogenase (LDH) . There were no great discrepancies in the rates of lymphopenia in peripheral blood, positive G-test, and increased LDH among different CT types (all P>0.05) . Conclusion: The initial chest CT findings of PJP in patients with hematological diseases were relatively prevalent with multiple GGO in both lungs. Nodular and fibrosis types were also the initial imaging findings for PJP.
		                        		
		                        		
		                        		
		                        			Male
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Pneumonia, Pneumocystis/diagnostic imaging*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Pneumocystis carinii
		                        			;
		                        		
		                        			Hematologic Diseases/complications*
		                        			;
		                        		
		                        			Tomography, X-Ray Computed
		                        			;
		                        		
		                        			Fibrosis
		                        			
		                        		
		                        	
2.Progress of researches on developmental processes and reproduction mode of Pneumocystis.
Chinese Journal of Schistosomiasis Control 2023;35(5):522-528
		                        		
		                        			
		                        			Pneumocystis, an important opportunistic fungal pathogen that parasitizes in multiple mammalian lungs, may cause life-threatening Pneumocystis pneumonia (PCP) and even death among immunocompromised individuals. With the rapid development of high-throughput sequencing and multi-omics technologies, systematic comparative analyses of genome, transcriptome, and whole-genome sequencing results demonstrate that Pneumocystis is a type of obligate biotrophic fungi, and requires obtaining nutrition from hosts. In addition, sexual reproduction is an essential process for Pneumocystis survival, production and transmission, and asexual reproduction facilitates Pneumocystis survival, which provides new insights into understanding of the whole developmental process of Pneumocystis in the host lung and inter-host transmission of Pneumocystis. This review summarizes the advances in the reproduction mode of Pneumocystis and underlying mechanisms, which provides insights into prevention and treatment of PCP, notably for the prophylaxis against nosocomial transmission of PCP.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lung/microbiology*
		                        			;
		                        		
		                        			Pneumocystis/genetics*
		                        			;
		                        		
		                        			Pneumonia, Pneumocystis/microbiology*
		                        			
		                        		
		                        	
3.Clinical Characteristic, Diagnosis and Treatment of Acute Lymphoblastic Leukemia Combined with Pneumocystis Carinii Pneumonia in Children.
Shao-Fen LIN ; Le-Le HOU ; Jian WANG ; Lyu-Hong XU ; Yong LIU ; You-Gang MAI ; Jian-Pei FANG ; Dun-Hua ZHOU
Journal of Experimental Hematology 2022;30(4):1079-1085
		                        		
		                        			OBJECTIVE:
		                        			To investigate the clinical characteristics and treatment of pneumocystis carinii pneumonia (PCP) in children with acute lymphoblastic leukemia (ALL), in order to improve the early diagnosis and effective treatment.
		                        		
		                        			METHODS:
		                        			Clinical data of five children with ALL developing PCP in the post-chemotherapy granulocyte deficiency phase were analyzed retrospectively. The clinical manifestations, laboratory tests, imaging findings, treatment methods and effect were summarized.
		                        		
		                        			RESULTS:
		                        			The male-to-female ratio of the five children was 1∶4, and the median age was 5.5 (2.9-8) years old. All patients developed PCP during granulocyte deficiency phase after induction remission chemotherapy. The clinical manifestations were generally non-specific, including high fever, tachypnea, dyspnea, non-severe cough, and rare rales in two lungs (wet rales in two patients). Laboratory tests showed elevated C-reactive protein (CRP), serum procalcitonin (PCT), (1,3)-β-D-glucan (BDG), lactate dehydrogenase (LDH) and inflammatory factors including IL-2R, IL-6 and IL-8. Chest CT showed diffuse bilateral infiltrates with patchy hyperdense shadows. Pneumocystis carinii(PC) was detected in bronchoalveolar lavage fluid (BALF) or induced sputum by high-throughput sequencing in all patients. When PCP was suspected, chemotherapy was discontinued immediately, treatment of trimethoprim-sulfame thoxazole (TMP-SMX) combined with caspofungin against PC was started, and adjunctive methylprednisolone was used. Meanwhile, granulocyte-stimulating factor and gammaglobulin were given as the supportive treatment. All patients were transferred to PICU receiving mechanical ventilation due to respiratory distress during treatment. Four children were cured and one died.
		                        		
		                        			CONCLUSION
		                        			PCP should be highly suspected in ALL children with high fever, dyspnea, increased LDH and BDG, and diffuse patchy hyperdense shadow or solid changes in lung CT. The pathogen detection of respiratory specimens should be improved as soon as possible. TMP/SMZ is the first-line drug against PCP, and the combination of Caspofungin and TMP/SMZ treatment for NH-PCP may have a better efficacy. Patients with moderate and severe NH-PCP may benefit from glucocorticoid.
		                        		
		                        		
		                        		
		                        			Caspofungin/therapeutic use*
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Dyspnea
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Pneumonia, Pneumocystis/therapy*
		                        			;
		                        		
		                        			Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy*
		                        			;
		                        		
		                        			Respiratory Sounds
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
4.Pneumocystis jirovecii Pneumonia in Patients with Lung Cancer: A Review.
Ting LI ; Jianying ZHOU ; Qing WANG
Chinese Journal of Lung Cancer 2022;25(4):272-277
		                        		
		                        			
		                        			In recent years, with the widespread use of immunodepressant agents, Pneumocystis jirovecii pneumonia (PJP) has been significantly found in non-human immunodeficiency virus (HIV) patients, such as those with malignancies, post-transplantation and autoimmune diseases. Although the risk factors and management of PJP have been extensively studied in the hematologic tumor and post-transplant populations, the research on real tumor cases is insufficient. Lung cancer has been the most common tumor with the highest number of incidence and death worldwide, and the prognosis of lung cancer patients infected with PJP is poor in clinical practice. By reviewing the previous studies, this paper summarized the epidemiology and clinical manifestations of PJP in lung cancer patients, the risk factors and possible mechanisms of PJP infection in lung cancer patients, diagnosis and prevention, and other research progresses to provide reference for clinical application.
.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Lung Neoplasms/complications*
		                        			;
		                        		
		                        			Pneumocystis carinii
		                        			;
		                        		
		                        			Pneumonia, Pneumocystis/diagnosis*
		                        			;
		                        		
		                        			Risk Factors
		                        			
		                        		
		                        	
5.Successful Treatment with Rituximab and Immunoadsorption for an Auto-Antibody Induced Bile Salt Export Pump Deficiency in a Liver Transplanted Patient
Jesús QUINTERO ; Javier JUAMPEREZ ; Emmanuel GONZALES ; Ecaterina JULIO ; Maria MERCADAL-HALLY ; Mauricette COLLADO-HILLY ; Ana MARÍN-SÁNCHEZ ; Ramon CHARCO
Pediatric Gastroenterology, Hepatology & Nutrition 2020;23(2):174-179
		                        		
		                        			
		                        			We present an 8 years old girl who was diagnosed at 6 months of age of Progressive Familial Intrahepatic Cholestasis type 2. Although liver transplantation (LT) was classically considered curative for these patients, cholestasis recurrence with normal gamma-glutamyl transpeptidase (GGT), mediated by anti-bile salt export pump (BSEP) antibodies after LT (auto-antibody Induced BSEP Deficiency, AIBD) has been recently reported. Our patient underwent LT at 14 months. During her evolution, patient presented three episodes of acute rejection. Seven years after the LT, the patient presented pruritus with cholestasis and elevation of liver enzymes with persistent normal GGT. Liver biopsy showed intrahepatic cholestasis and giant-cell transformation with very low BSEP activity. Auto-antibodies against BSEP were detected therefore an AIBD was diagnosed. She was treated with Rituximab and immunoadsorption with resolution of the AIBD. As a complication of the treatment she developed a pneumocystis infection successfully treated with corticoids, cotrimoxazol and anidulafungin.
		                        		
		                        		
		                        		
		                        			Adrenal Cortex Hormones
		                        			;
		                        		
		                        			Antibodies
		                        			;
		                        		
		                        			Bile
		                        			;
		                        		
		                        			Biopsy
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Cholestasis
		                        			;
		                        		
		                        			Cholestasis, Intrahepatic
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			gamma-Glutamyltransferase
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liver Transplantation
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Pneumocystis Infections
		                        			;
		                        		
		                        			Pruritus
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Rituximab
		                        			
		                        		
		                        	
6.A school-aged boy with nephrotic syndrome with cough for one month and shortness of breath for half a month.
Xiao-Lu DENG ; Chun-Guang ZHAO ; Xin-Hua MA ; Xia WANG
Chinese Journal of Contemporary Pediatrics 2020;22(12):1326-1330
		                        		
		                        			
		                        			A boy, aged 6 years and 11 months, was admitted due to nephrotic syndrome for 2 years, cough for 1 month, and shortness of breath for 15 days. The boy had a history of treatment with hormone and immunosuppressant. Chest CT after the onset of cough and shortness of breath showed diffuse ground-glass opacities in both lungs. Serum (1, 3)-beta-D glucan was tested positive, and the nucleic acid of cytomegalovirus was detected in respiratory secretions. After the anti-fungal and anti-viral treatment, the child improved temporarily but worsened again within a short period of time.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			Cough/etiology*
		                        			;
		                        		
		                        			Cytomegalovirus Infections/therapy*
		                        			;
		                        		
		                        			Dyspnea/etiology*
		                        			;
		                        		
		                        			Extracorporeal Membrane Oxygenation
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Nephrotic Syndrome/complications*
		                        			;
		                        		
		                        			Pneumonia, Pneumocystis/therapy*
		                        			;
		                        		
		                        			Respiratory Distress Syndrome/therapy*
		                        			
		                        		
		                        	
7.A Stepwise Diagnostic Approach to Cystic Lung Diseases for Radiologists
Kyu Chong LEE ; Eun Young KANG ; Hwan Seok YONG ; Cherry KIM ; Ki Yeol LEE ; Sung Ho HWANG ; Yu Whan OH
Korean Journal of Radiology 2019;20(9):1368-1380
		                        		
		                        			
		                        			Lung cysts are commonly seen on computed tomography (CT), and cystic lung diseases show a wide disease spectrum. Thus, correct diagnosis of cystic lung diseases is a challenge for radiologists. As the first diagnostic step, cysts should be distinguished from cavities, bullae, pneumatocele, emphysema, honeycombing, and cystic bronchiectasis. Second, cysts can be categorized as single/localized versus multiple/diffuse. Solitary/localized cysts include incidental cysts and congenital cystic diseases. Multiple/diffuse cysts can be further categorized according to the presence or absence of associated radiologic findings. Multiple/diffuse cysts without associated findings include lymphangioleiomyomatosis and Birt-Hogg-Dubé syndrome. Multiple/diffuse cysts may be associated with ground-glass opacity or small nodules. Multiple/diffuse cysts with nodules include Langerhans cell histiocytosis, cystic metastasis, and amyloidosis. Multiple/diffuse cysts with ground-glass opacity include pneumocystis pneumonia, desquamative interstitial pneumonia, and lymphocytic interstitial pneumonia. This stepwise radiologic diagnostic approach can be helpful in reaching a correct diagnosis for various cystic lung diseases.
		                        		
		                        		
		                        		
		                        			Amyloidosis
		                        			;
		                        		
		                        			Birt-Hogg-Dube Syndrome
		                        			;
		                        		
		                        			Bronchiectasis
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Emphysema
		                        			;
		                        		
		                        			Histiocytosis
		                        			;
		                        		
		                        			Histiocytosis, Langerhans-Cell
		                        			;
		                        		
		                        			Lung Diseases
		                        			;
		                        		
		                        			Lung Diseases, Interstitial
		                        			;
		                        		
		                        			Lung
		                        			;
		                        		
		                        			Lymphangioleiomyomatosis
		                        			;
		                        		
		                        			Neoplasm Metastasis
		                        			;
		                        		
		                        			Pneumonia, Pneumocystis
		                        			
		                        		
		                        	
8.Epidemiological characteristics of HIV infected Korean: Korea HIV/AIDS Cohort Study
Yunsu CHOI ; Bo Youl CHOI ; Soo Min KIM ; Sang Il KIM ; June KIM ; Jun Young CHOI ; Shin Woo KIM ; Joon Young SONG ; Youn Jeong KIM ; Dae Won PARK ; Hyo Youl KIM ; Hee Jung CHOI ; Mee Kyung KEE ; Young Hyun SHIN ; Myeongsu YOO
Epidemiology and Health 2019;41(1):2019037-
		                        		
		                        			
		                        			OBJECTIVES: To manage evidence-based diseases, it is important to identify the characteristics of patients in each country.METHODS: The Korea HIV/AIDS Cohort Study seeks to identify the epidemiological characteristics of 1,442 Korean individuals with human immunodeficiency virus (HIV) infection (12% of Korean individuals with HIV infection in 2017) who visited 21 university hospitals nationwide. The descriptive statistics were presented using the Korea HIV/AIDS cohort data (2006-2016).RESULTS: Men accounted for 93.3% of the total number of respondents, and approximately 55.8% of respondents reported having an acute infection symptom. According to the transmission route, infection caused by sexual contact accounted for 94.4%, of which 60.4% were caused by sexual contact with the same sex or both males and females. Participants repeatedly answered the survey to decrease depression and anxiety scores. Of the total participants, 89.1% received antiretroviral therapy (ART). In the initial ART, 95.3% of patients were treated based on the recommendation. The median CD4 T-cell count at the time of diagnosis was 229.5 and improved to 331 after the initial ART. Of the patients, 16.6% and 9.4% had tuberculosis and syphilis, respectively, and 26.7% had pneumocystis pneumonia. In the medical history, sexually transmitted infectious diseases showed the highest prevalence, followed by endocrine diseases. The main reasons for termination were loss to follow-up (29.9%) and withdrawal of consent (18.7%).CONCLUSIONS: Early diagnosis and ART should be performed at an appropriate time to prevent the development of new infection.
		                        		
		                        		
		                        		
		                        			AIDS-Related Opportunistic Infections
		                        			;
		                        		
		                        			Anxiety
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Communicable Diseases
		                        			;
		                        		
		                        			Depression
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Early Diagnosis
		                        			;
		                        		
		                        			Endocrine System Diseases
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			HIV Infections
		                        			;
		                        		
		                        			HIV
		                        			;
		                        		
		                        			Hospitals, University
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Pneumonia, Pneumocystis
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Surveys and Questionnaires
		                        			;
		                        		
		                        			Syphilis
		                        			;
		                        		
		                        			T-Lymphocytes
		                        			;
		                        		
		                        			Tuberculosis
		                        			
		                        		
		                        	
9.A Case of Severe Pneumocystis Pneumonia in a Thyroid Cancer Patient Receiving Lenvatinib
Mei Hua JIN ; Won Gu KIM ; Tae Yong KIM ; Won Bae KIM ; Young Kee SHONG ; Min Ji JEON
International Journal of Thyroidology 2019;12(2):127-131
		                        		
		                        			
		                        			Lenvatinib is a multitargeted tyrosine kinase inhibitor approved for use in patients with iodine-131–refractory thyroid cancer. The common adverse events of lenvatinib include hypertension, proteinuria, fatigue, and diarrhea. To date, no report on Pneumocystis pneumonia (PCP) in patients receiving lenvatinib has been published. Here, we present a case of severe PCP that led to the death of a 79-year-old woman who was diagnosed with poorly differentiated thyroid cancer and received lenvatinib. The development of PCP should be considered when patients taking lenvatinib show clinical symptoms of pneumonia, and regular chest X-ray follow-up is needed for patients receiving lenvatinib.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Diarrhea
		                        			;
		                        		
		                        			Fatigue
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypertension
		                        			;
		                        		
		                        			Lung Diseases, Interstitial
		                        			;
		                        		
		                        			Pneumocystis
		                        			;
		                        		
		                        			Pneumonia
		                        			;
		                        		
		                        			Pneumonia, Pneumocystis
		                        			;
		                        		
		                        			Protein-Tyrosine Kinases
		                        			;
		                        		
		                        			Proteinuria
		                        			;
		                        		
		                        			Thorax
		                        			;
		                        		
		                        			Thyroid Gland
		                        			;
		                        		
		                        			Thyroid Neoplasms
		                        			
		                        		
		                        	
10.Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumoni.
Infection and Chemotherapy 2018;50(3):266-267
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Bronchoalveolar Lavage Fluid*
		                        			;
		                        		
		                        			Bronchoalveolar Lavage*
		                        			;
		                        		
		                        			Lymphocytes*
		                        			;
		                        		
		                        			Pneumocystis jirovecii*
		                        			;
		                        		
		                        			Pneumocystis*
		                        			;
		                        		
		                        			Risk Factors*
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail